Cellectar Biosciences, Inc.

8-K Director or officer change; Shareholder vote results Jul 10, 2026 8-K Director or officer change May 18, 2026 8-K Results of operations (earnings release) May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events May 8, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Results of operations (earnings release) Mar 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Modified rights of security holders; Other events Oct 10, 2025 8-K Regulation FD disclosure; Other events Oct 6, 2025 8-K Results of operations (earnings release) Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Other events Jun 26, 2025 8-K Modified rights of security holders; Amended charter or bylaws Jun 25, 2025 8-K Other events Jun 18, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Regulation FD disclosure Jun 5, 2025 8-K Results of operations (earnings release) May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Other events May 1, 2025 8-K Director or officer change; Amended charter or bylaws Mar 17, 2025 8-K Results of operations (earnings release) Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Delisting notice or listing-rule failure Jan 31, 2025 8-K Regulation FD disclosure Jan 14, 2025 8-K Exit or disposal costs; Regulation FD disclosure; Other events Dec 11, 2024 8-K Results of operations (earnings release) Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 18, 2024 8-K Other events Nov 15, 2024 8-K Other events Nov 1, 2024 10-Q Quarter ended 2024-06-30 Oct 29, 2024 10-Q/A Quarter ended 2024-03-31 Oct 29, 2024 10-K/A Fiscal year ended 2023-12-31 Oct 29, 2024 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Aug 23, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Previously issued financials not reliable Aug 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jul 23, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Regulation FD disclosure Jul 22, 2024